Japanese Journal of Cancer Research · 1990 · 18 citations · 18 references
MedicineOncologyPathologyCancer ImmunologyGastrointestinal OncologyTumor ImmunologyBiomarkers In PathologyCancer BiomarkersGastrointestinal PathologyTumor AntigensTumor MarkersTumor-associated AntigensAntigen Detection In StoolAssayCancer AntigensClinical Cancer DiagnosisFecal BiomarkersPhospholipase C PathwayTumor Antigen IdentificationTumor Marker Assays
About 50-70 mg in total of carcinoembryonic antigen (CEA) (or CEA-related antigens) was detected in normal adult feces evacuated during one day (200-250 g). Ten percent or less of the antigen was found to be in soluble form in fresh feces (naturally solubilized antigen), while 90% or more was still in membrane-bound form which was releasable with phosphatidylinositol-specific phospholipase C (PI-PLC-solubilized antigen). The naturally solubilized and PI-PLC-solubilized antigens are antigenically different from each other and similar to normal fecal antigen (NFA)-2 and CEA, respectively, suggesting that "CEA-distinctive" antigenicity detected so far in CEA from cancerous tissues is not due to the difference between antigens in normal and malignant tissues but is probably due to the presence of the glycosylinositolphosphate moiety at the carboxyl-terminus of the antigen molecule. Thus, "CEA-distinctive" antigenicity is by no means cancer-specific, but this antigenicity seems to be critical for the clinical significance of CEA as a tumor marker, because an assay system (Kit II) which is able to distinguish CEA from NFA-2 revealed much improved features in cancer diagnosis as reported recently.
18
Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule
Sarita Benchimol, Abraham Fuks, Serge Jothy et al. · Cell · 1989 · 981 citations
Shinzo Oikawa, Chikako Inuzuka, Motomu Kuroki et al. · Biochemical and Biophysical Research Communications · 1989 · 238 citations